MOTS-C (Mitochondrial ORF of the 12S rRNA type-c) is a peptide encoded within the mitochondrial genome rather than the nuclear genome — a characteristic that makes it biologically unusual and has driven significant research interest since its discovery in 2015. Unlike most peptides studied in metabolic research, MOTS-c originates within the mitochondria themselves, leading researchers to categorize it as a mitochondrial-derived peptide (MDP) and to examine its role as both an intracellular and endocrine signaling molecule.
MOTS-c was identified by researchers at the University of Southern California in a 2015 study published in Cell Metabolism. The discovery was notable because MOTS-c is encoded within the 12S ribosomal RNA gene of mitochondrial DNA — a region previously thought to contain only structural RNA sequences rather than protein-coding open reading frames. MOTS-c is a 16-amino acid peptide (MRWQEMGYIFYPRKLR) detected in both intracellular and circulating compartments.
Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443–454.
The primary mechanism researchers have focused on is MOTS-c’s activation of AMP-activated protein kinase (AMPK) — the master energy-sensing enzyme that regulates cellular metabolism in response to energetic stress. AMPK activation is associated in the published literature with increased glucose uptake, enhanced fatty acid oxidation, improved insulin sensitivity, and mitochondrial biogenesis. The original Lee et al. study reported that MOTS-c activated AMPK in skeletal muscle cells, leading to increased glucose uptake through a pathway described as partially independent of the classic insulin receptor pathway.
Skeletal muscle is the primary tissue examined in published MOTS-c research, as it accounts for the majority of insulin-stimulated glucose uptake. The Lee et al. study reported improved insulin sensitivity and reduced adiposity in obese mouse models. A 2021 study by Reynolds et al. (Nature Communications) examined MOTS-c plasma levels in humans across age groups and fitness levels, reporting positive association with physical fitness and negative association with age.
Reynolds JC, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline. Nat Commun. 2021;12:470.
MOTS-c has been characterized in published research as a potential ‘exercise mimetic’ — a compound that activates metabolic pathways associated with physical exercise. This emerged from findings showing that MOTS-c administration in sedentary mouse models produced metabolic improvements partially resembling exercise training effects. Published research has also documented that circulating MOTS-c levels decline with age in both animal models and human cohort studies.
For informational purposes only. Not medical advice or dosing guidance.
